Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report.
Kiichiro NinomiyaDaisuke EnnishiKunio OkamotoMidori AndoSatoko NakamuraShuta TomidaYoshiyuki AyadaGo MakimotoEiki IchiharaNatsuko OkitaShinichi ToyookaYoshinobu MaedaMasahiro TabataPublished in: JCO precision oncology (2024)
Imatinib may be a useful targeted agent for patients with advanced gastric adenocarcinoma who have KIT mutations.